Skip to content

Comparison of Intrathecal Fentanyl versus Transverse Abdominis Plane Block for Postoperative pain relief in Pregnant Patients Undergoing Elective Caesarean Section

Comparison of Intrathecal Fentanyl versus Transverse Abdominis Plane Block for Postoperative Analgesia in Pregnant Patients Undergoing Elective Caesarean Section-A randomized control trial - nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/110689
Enrollment
50
Registered
2026-05-20
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Intrathecal Fentanyl for Postoperative Analgesia in Pregnant Patients Undergoing Elective Caesarean Section: Group F patients will receive subarachnoid block with 10 mg of 0.5% bupivaca

Sponsors

Dr S Hema Chandana
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Age group: 21-45 years women having gestational age more than 37 weeks 2 Elective caesarean deliveries done under spinal anaesthesia 3 ASA (American Society Of Anaesthesiologists) physical status II

Exclusion criteria

Exclusion criteria: 1 Refusal to enrol for the study 2 Any contraindications for spinal anaesthesia 3 Multiple gestation 4 Patients with Hypertensive disorders of pregnancy 5 Patients with Uncontrolled diabetes mellitus 6 Patients with BMI more than 35kg/m2 7 Patients with other obstetric complications during surgery like bladder injury, bowel injury [will be excluded after surgery]

Design outcomes

Primary

MeasureTime frame
To compare the duration of analgesia of intrathecal fentanyl group Group F with ultrasound-guided transversus abdominis plane block group Group T after elective caesarean section To compare the duration of sensory and motor blockade between Group F and Group T.Timepoint: postop 24hrs

Secondary

MeasureTime frame
1 To compare the analgesic efficacy between Group F and Group T. 2 To assess the total analgesic consumption in 24 h in Group F and Group T 3 To evaluate the neonatal APGAR score at 1 and 5 mins in Group F and Group T 4 To assess the incidence of nausea and vomiting in Group F and Group TTimepoint: postop 24hrs

Countries

India

Contacts

Public ContactDr Mahindra B Kalashetty

SNMC and HSK hospital

mahindra2936@gmail.com09449551654

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026